Back to Search
RUPINDER SINGH, M.D.
M.D.
Internal Medicine Physician
NPI: 1336128131Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
36289(CO)
Research & Publications (20)
Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.
PMID 19147767·Clin Cancer Res·2009
7-preclinical
Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice.
PMID 19047104·Clin Cancer Res·2008
7-preclinical
Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
PMID 18339887·Cancer Res·2008
7-preclinical
Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
PMID 18172282·Clin Cancer Res·2008
7-preclinical
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
PMID 17916909·Carcinogenesis·2007
7-preclinical
Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents.
PMID 17691907·Curr Cancer Drug Targets·2007
6-review
Mechanisms of action of novel agents for prostate cancer chemoprevention.
PMID 16954429·Endocr Relat Cancer·2006
6-review
Effect of silibinin on the growth and progression of primary lung tumors in mice.
PMID 16788158·J Natl Cancer Inst·2006
7-preclinical
Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells.
PMID 16731746·Mol Cancer Ther·2006
7-preclinical
Prostate cancer chemoprevention by silibinin: bench to bedside.
PMID 16637061·Mol Carcinog·2006
6-review
Natural flavonoids targeting deregulated cell cycle progression in cancer cells.
PMID 16515531·Curr Drug Targets·2006
6-review
Mechanisms and preclinical efficacy of silibinin in preventing skin cancer.
PMID 16084079·Eur J Cancer·2005
6-review
Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
PMID 15558015·Oncogene·2005
8-other
Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
PMID 15623648·Clin Cancer Res·2004
4-observational
A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer.
PMID 15476849·Mutat Res·2004
6-review
In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor.
PMID 14734476·Clin Cancer Res·2004
7-preclinical
Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and upregulates insulin-like growth factor binding protein-3.
PMID 14696100·Int J Cancer·2004
7-preclinical
Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
PMID 14504208·Cancer Epidemiol Biomarkers Prev·2003
4-observational
Tumor angiogenesis: a potential target in cancer control by phytochemicals.
PMID 12769689·Curr Cancer Drug Targets·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 950 E HARVARD AVE, SUITE 200
DENVER, CO 80210 - Phone
- (303) 649-3200
Quick Facts
- NPI
- 1336128131
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile